References
Douketis JD (2001) Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice. Am J Cardiovasc Drugs 1(4):245–251
Ansell JE (1999) Empowering patients to monitor and manage oral anticoagulation therapy. JAMA 281(2):182–183
Heneghan C, Ward A, Perera R, Self-Monitoring Trialist Collaboration, Bankhead C, Fuller A, Stevens R, Bradford K, Tyndel S, Alonso-Coello P, Ansell J, Beyth R, Bernardo A, Christensen TD, Cromheecke ME, Edson RG, Fitzmaurice D, Gadisseur AP, Garcia-Alamino JM, Gardiner C, Hasenkam JM, Jacobson A, Kaatz S, Kamali F, Khan TI, Knight E, Körtke H, Levi M, Matchar D, Menéndez-Jándula B, Rakovac I, Schaefer C, Siebenhofer A, Souto JC, Sunderji R, Gin K, Shalansky K, Völler H, Wagner O, Zittermann A (2012) Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 379(9813):322–334
Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH (2008) Feasibility, cost-effectiveness and patients’ acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Ann Hematol 87(11):905–910
Financial support information
Nil.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lai, Y.F., Kong, M.C., Chan, F.S.L. et al. Agreement of point-of-care INR test with standard venous sampling assay at higher extreme ranges. Ann Hematol 94, 1407–1408 (2015). https://doi.org/10.1007/s00277-015-2371-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2371-6